Marilixibat chloride Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Marilixibat chloride is an oral small-molecule ileal bile acid transporter (IBAT) inhibitor developed by Mirum Pharmaceuticals and approved by the USFDA for cholestatic pruritus in patients with Alagille syndrome (ALGS). IBAT facilitates reabsorption of bile acids from the ileum and is a key facilitator of bile acid enterohepatic recirculation. Similar to surgical interruption of enterohepatic recirculation, it was shown that inhibition of IBAT with 22 reduced pruritis in patients with ALGS.

Marilixibat chloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Marilixibat chloride Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Wuhan Demeikai Biotechnology Co., Ltd	+8618942921723	info@dmksw.xin	China	717	58
TargetMol Chemicals Inc.		support@targetmol.com	United States	38631	58
Wuhan Topule Biopharmaceutical Co., Ltd	+8618327326525	masar@topule.com	China	8467	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	52924	58
Shanghai Chaolan Chemical Technology Center	021-QQ：65489617 15618227136	Sales@ATKchemical.com	China	7298	58
Guangzhou Belka Biological Technology Co., Ltd.	+86-18665676617		China	957	58
ShangHai ChuanQian Chemcial Technique Centre	15869524721	3525679403@qq.com	China	4320	58
BEIJING INNO-TECH PHARMIC TECHNOLOGY CO.,LTD	15011485209		China	145	58
JinOu Biomedical (Nanjing) Co., Ltd.	13000000000	jinoupharma@163.com	China	11721	58
Wuhan Biocar Pharmacy Co.，Ltd	18665676617	2956176220@qq.com	China	61	58

---

• HP-625)
• Lopixibat chloride (LUM-001
• Maralixibat?chloride
• Maralixibat chloride (Lopixibat chloride)
• Maralixibat
• Livmarli
• Lopixibat
• SHP 625
• SHP625
• SHP-625
• SHP625/ LUM001/Maralixibat chloride
• Marilixibat chloride
• 228113-66-4